Affinergy, a developer of biomaterial coatings for the surface of synthetic materials such as artificial joints, is beefing up its management teams.
Paul Hamilton joins the company as director of research and development, and Wayne is director of protein chemistry.
Hamilton joins Affinergy from Karo Bio USA where he was vice president of research and development. He also worked 11 years at Becton Dickinson.
Beyer was director of proteomics research and rare reagents research and development at Tripath Oncology. He also worked at Becton Dickinson for eight years.